Physician profile
Brian Day
NPI 1659955623
$610.43
in general payments reported to CMS, 2019-2025
11 companies · $557 in 2025
The $557 reported for 2025 was more than what 91% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $53.56 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $610.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $140.08 | 2024-2025 | Evenity |
| Merck Sharp & Dohme LLC | $94.62 | 2025 | Verquvo, Zerbaxa |
| Viatris Specialty LLC | $94.49 | 2025 | Yupelri |
| Abbvie INC. | $78.15 | 2025 | |
| Stryker Corporation | $40.24 | 2025 | Flowtriever |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.03 | 2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $33.67 | 2024-2025 | |
| Cvrx, INC. | $31.74 | 2025 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $26.88 | 2025 | Uptravi |
| Pfizer INC. | $17.38 | 2024 | |
| Melinta Therapeutics, LLC | $15.15 | 2025 | Rezzayo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Day listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.